Press Releases and News Releases for Year 2012
Jun 13, 2012 PR
Clarification of Prior Press Release on FDA Issuance of Orphan Status for PermaDerm®.
Clarifies the designation of "Orphan Status" used in the earlier press release on June 12, 2012.
Jun 12, 2012 PR
FDA Issues Orphan Status Approval for PermaDerm®. Regenicin, Inc. announces that the Food and Drug Administration (FDA) has granted Orphan Status approval for the PermaDerm® product, the only tissue-engineered skin prepared from autologous (patient's own) skin cells consisting of both epidermal and dermal layers.
Pr: Press Release
NR: News Release